Smith & Nephew Journey BCS knee implant recalled for higher-than-expected revision rates
Contact your surgeon about Smith & Nephew knee implant
Smith & Nephew's first-generation Journey BCS Knee System has shown a revision rate (need for replacement surgery) that is over 1.5 times higher than the average for similar knee implants, based on data from medical registries in the UK, Australia, and other countries. The implant is used in knee replacement surgery.
- If you received this implant, contact your orthopedic surgeon to discuss whether monitoring or follow-up care is needed
- Ask your surgeon about your specific implant model and what symptoms to watch for
- Keep all follow-up appointments with your surgeon
The data in the National Joint Registry of England, Wales and Northern Ireland (NJREWNI) and Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) indicate that the first generation JOURNEY BCS Knee System has a revision rate over 1.5 times the primary total knee arthroplasty device class average revision rates reported in those registries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0001-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief